Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters











Publication year range
1.
Mar Drugs ; 18(8)2020 Aug 13.
Article in English | MEDLINE | ID: mdl-32823677

ABSTRACT

Recently, Conorfamide-Sr3 (CNF-Sr3) was isolated from the venom of Conus spurius and was demonstrated to have an inhibitory concentration-dependent effect on the Shaker K+ channel. The voltage-gated potassium channels play critical functions on cellular signaling, from the regeneration of action potentials in neurons to the regulation of insulin secretion in pancreatic cells, among others. In mammals, there are at least 40 genes encoding voltage-gated K+ channels and the process of expression of some of them may include alternative splicing. Given the enormous variety of these channels and the proven use of conotoxins as tools to distinguish different ligand- and voltage-gated ion channels, in this work, we explored the possible effect of CNF-Sr3 on four human voltage-gated K+ channel subtypes homologous to the Shaker channel. CNF-Sr3 showed a 10 times higher affinity for the Kv1.6 subtype with respect to Kv1.3 (IC50 = 2.7 and 24 µM, respectively) and no significant effect on Kv1.4 and Kv1.5 at 10 µM. Thus, CNF-Sr3 might become a novel molecular probe to study diverse aspects of human Kv1.3 and Kv1.6 channels.


Subject(s)
Mollusk Venoms/pharmacology , Potassium Channel Blockers/pharmacology , Shaker Superfamily of Potassium Channels/antagonists & inhibitors , Animals , Conus Snail , Ion Channel Gating , Kv1.3 Potassium Channel/antagonists & inhibitors , Kv1.3 Potassium Channel/genetics , Kv1.3 Potassium Channel/metabolism , Kv1.4 Potassium Channel/antagonists & inhibitors , Kv1.4 Potassium Channel/genetics , Kv1.4 Potassium Channel/metabolism , Kv1.5 Potassium Channel/antagonists & inhibitors , Kv1.5 Potassium Channel/genetics , Kv1.5 Potassium Channel/metabolism , Kv1.6 Potassium Channel/antagonists & inhibitors , Kv1.6 Potassium Channel/genetics , Kv1.6 Potassium Channel/metabolism , Membrane Potentials , Oocytes , Shaker Superfamily of Potassium Channels/genetics , Shaker Superfamily of Potassium Channels/metabolism , Xenopus laevis
2.
Front Immunol ; 11: 428, 2020.
Article in English | MEDLINE | ID: mdl-32231667

ABSTRACT

Gastropod Molluscs rely exclusively on the innate immune system to protect from pathogens, defending their embryos through maternally transferred effectors. In this regard, Pomacea snail eggs, in addition to immune defenses, have evolved the perivitellin-2 or PV2 combining two immune proteins into a neurotoxin: a lectin and a pore-forming protein from the Membrane Attack Complex/Perforin (MACPF) family. This binary structure resembles AB-toxins, a group of toxins otherwise restricted to bacteria and plants. Many of these are enterotoxins, leading us to explore this activity in PV2. Enterotoxins found in bacteria and plants act mainly as pore-forming toxins and toxic lectins, respectively. In animals, although both pore-forming proteins and lectins are ubiquitous, no enterotoxins have been reported. Considering that Pomacea snail eggs ingestion induce morpho-physiological changes in the intestinal mucosa of rodents and is cytotoxic to intestinal cells in culture, we seek for the factor causing these effects and identified PmPV2 from Pomacea maculata eggs. We characterized the enterotoxic activity of PmPV2 through in vitro and in vivo assays. We determined that it withstands the gastrointestinal environment and resisted a wide pH range and enzymatic proteolysis. After binding to Caco-2 cells it promoted changes in surface morphology and an increase in membrane roughness. It was also cytotoxic to both epithelial and immune cells from the digestive system of mammals. It induced enterocyte death by a lytic mechanism and disrupted enterocyte monolayers in a dose-dependent manner. Further, after oral administration to mice PmPV2 attached to enterocytes and induced large dose-dependent morphological changes on their small intestine mucosa, reducing the absorptive surface. Additionally, PmPV2 was detected in the Peyer's patches where it activated lymphoid follicles and triggered apoptosis. We also provide evidence that the toxin can traverse the intestinal barrier and induce oral adaptive immunity with evidence of circulating antibody response. As a whole, these results indicate that PmPV2 is a true enterotoxin, a role that has never been reported to lectins or perforin in animals. This extends by convergent evolution the presence of plant- and bacteria-like enterotoxins to animals, thus expanding the diversity of functions of MACPF proteins in nature.


Subject(s)
Enterotoxins/pharmacology , Immunity, Innate/immunology , Intestinal Mucosa/drug effects , Mollusk Venoms/pharmacology , Snails/immunology , Animals , Complement Membrane Attack Complex , Mice , Ovum/immunology , Ovum/metabolism , Perforin/metabolism
3.
Toxicon ; 138: 53-58, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28774677

ABSTRACT

Conorfamides (CNFs) are toxins initially characterized from the venom duct of the venomous marine snail Conus spurius from the Gulf of Mexico; at their C-termini, these toxins are amidated and have high sequence similarity with the molluskan cardioexcitatory tetrapeptide Phe-Met-Arg-Phe-NH2 (FMRFamide or FMRFa) and other FMRFa-related peptides (FaRPs) found in the five molluskan classes, and in other invertebrate and vertebrate phyla. These peptides were the first FaRPs found to be present in any venom, and they are biologically active in mice, limpets, and/or freshwater snails. However, the molecular targets of the known CNFs (CNF-Sr1 and CNF-Sr2 from C. spurius, and CNF-Vc1 from C. victoriae) remain unidentified. Very recently, three FaRPs from C. textile have been found to potentiate the currents of acid-sensing ion channels. In this work, we characterized a novel conorfamide, CNF-Sr3 (ATSGPMGWLPVFYRF-NH2), comprised of 15 amino acid residues, and with a specific blocking activity for the Shaker subtype of the voltage-gated potassium channels, without significant effect on the Shab, Shaw, Shal and Eag channels. This peptide is the third type of disulfide-free conotoxins that has been discovered to target K+ channels.


Subject(s)
Conus Snail/chemistry , Mollusk Venoms/chemistry , Neuropeptides/pharmacology , Peptides/pharmacology , Shaker Superfamily of Potassium Channels/antagonists & inhibitors , Amino Acid Sequence , Animals , Baculoviridae , HEK293 Cells , Humans , Mollusk Venoms/chemical synthesis , Mollusk Venoms/pharmacology , Neuropeptides/chemical synthesis , Neuropeptides/chemistry , Peptides/chemistry , Potassium Channel Blockers/chemistry , Potassium Channel Blockers/pharmacology , Sf9 Cells/virology
4.
Toxins (Basel) ; 8(2): 38, 2016 Feb 05.
Article in English | MEDLINE | ID: mdl-26861394

ABSTRACT

Lung cancer is one of the most common types of cancer in men and women and a leading cause of death worldwide resulting in more than one million deaths per year. The venom of marine snails Conus contains up to 200 pharmacologically active compounds that target several receptors in the cell membrane. Due to their diversity and specific binding properties, Conus toxins hold great potential as source of new drugs against cancer. We analyzed the cytotoxic effect of a 17-amino acid synthetic peptide (s-cal14.1a) that is based on a native toxin (cal14.1a) isolated from the sea snail Conus californicus. Cytotoxicity studies in four lung cancer cell lines were complemented with measurement of gene expression of apoptosis-related proteins Bcl-2, BAX and the pro-survival proteins NFκB-1 and COX-2, as well as quantification of caspase activity. Our results showed that H1299 and H1437 cell lines treated with s-call4.1a had decreased cell viability, activated caspases, and reduced expression of the pro-survival protein NFκB-1. To our knowledge, this is the first report describing activation of apoptosis in human lung cancer cell lines by s-cal14.1a and we offer insight into the possible mechanism of action.


Subject(s)
Antineoplastic Agents/pharmacology , Mollusk Venoms/pharmacology , Peptides/pharmacology , Animals , Apoptosis/drug effects , Caspase 3/metabolism , Caspase 7/metabolism , Cell Line, Tumor , Conus Snail , Cyclooxygenase 2/genetics , Gene Expression Regulation, Neoplastic/drug effects , Humans , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , NF-kappa B/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , RNA, Messenger/metabolism , bcl-2-Associated X Protein/genetics
5.
J. venom. anim. toxins incl. trop. dis ; J. venom. anim. toxins incl. trop. dis;19: 10-10, maio 2013. ilus, tab
Article in English | LILACS | ID: lil-686610

ABSTRACT

Background: It is estimated that venoms of marine cone snails (genus Conus) contain more than 100,000 different small peptides with a wide range of pharmacological and biological actions. Some of these peptides were developed into potential therapeutic agents and as molecular tools to understand biological functions of nervous and cardiovascular systems. In this study we examined the cytotoxic and anticancer properties of the marine vermivorous cone snail Conus vexillum (collected from Hurgada and Sharm El-Shaikh, Red Sea, Egypt) and suggest the possible mechanisms involved. The in vitro cytotoxic effects of Conus venom were assessed against Ehrlich's ascites carcinoma (EAC) cells. Results: Conus venom treatment resulted in concentration-dependent cytotoxicity as indicated by a lactate dehydrogenase leakage assay. Apoptotic effects were measured in vivo by measuring levels of reactive oxygen species and oxidative defense agents in albino mice injected with EAC cells. Conus venom (1.25 mg/kg) induced a significant increase (p < 0.05) in several oxidative stress biomarkers (lipid peroxidation, protein carbonyl content and reactive nitrogen intermediates) of EAC cells after 3, 6, 9 and 12 hours of venom injection. Conus venom significantly reduced (p < 0.05) the activities of oxidative defense enzymes (catalase and superoxide dismutase) as well as the total antioxidant capacity of EAC cells, as evidenced by lowered levels of reduced glutathione. Conclusions: These results demonstrate the cytotoxic potential of C. vexillum venom by inducing oxidative stress mediated mechanisms in tumor cells and suggest that the venom contains novel molecules with potential anticancer activity.(AU)


Subject(s)
Animals , Male , Mice , Carcinoma, Ehrlich Tumor , Oxidative Stress , Conus Snail/cytology , Mollusk Venoms/toxicity , Mollusk Venoms/pharmacology , In Vitro Techniques , Apoptosis/physiology , Egypt , Antineoplastic Agents/pharmacology
6.
Peptides ; 29(2): 186-95, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18201803

ABSTRACT

A novel peptide, conorfamide-Sr2 (CNF-Sr2), was purified from the venom extract of Conus spurius, collected in the Caribbean Sea off the Yucatan Peninsula. Its primary structure was determined by automated Edman degradation and amino acid analysis, and confirmed by electrospray ionization mass spectrometry. Conorfamide-Sr2 contains 12 amino acids and no Cys residues, and it is only the second FMRFamide-related peptide isolated from a venom. Its primary structure GPM gammaDPLgammaIIRI-nh2, (gamma, gamma-carboxyglutamate; -nh2, amidated C-terminus; calculated monoisotopic mass, 1468.72Da; experimental monoisotopic mass, 1468.70Da) shows two features that are unusual among FMRFamide-related peptides (FaRPs, also known as RFamide peptides), namely the novel presence of gamma-carboxyglutamate, and a rather uncommon C-terminal residue, Ile. CNF-Sr2 exhibits paralytic activity in the limpet Patella opea and causes hyperactivity in the freshwater snail Pomacea paludosa and in the mouse. The sequence similarities of CNF-Sr2 with FaRPs from marine and freshwater mollusks and mice might explain its biological effects in these organisms. It also resembles FaRPs from polychaetes (the prey of C. spurius), which suggests a natural biological role. Based on these similarities, CNF-Sr2 might interact with receptors of these three distinct types of FaRPs, G-protein-coupled receptors, Na+ channels activated by FMRFamide (FaNaCs), and acid-sensing ion channels (ASICs). The biological activities of CNF-Sr2 in mollusks and mice make it a potential tool to study molecular targets in these and other organisms.


Subject(s)
1-Carboxyglutamic Acid/chemistry , Conus Snail/chemistry , FMRFamide/chemistry , Mollusk Venoms/chemistry , Neuropeptides/chemistry , Peptides/chemistry , Amino Acid Sequence , Amino Acids/analysis , Animals , Behavior, Animal/drug effects , Central Nervous System/drug effects , Central Nervous System/physiology , Male , Mice , Mice, Inbred Strains , Molecular Weight , Mollusca , Mollusk Venoms/isolation & purification , Mollusk Venoms/pharmacology , Motor Activity/drug effects , Muscles/drug effects , Muscles/physiology , Neuropeptides/isolation & purification , Neuropeptides/pharmacology , Peptides/isolation & purification , Peptides/pharmacology , Poecilia , Sequence Analysis, Protein , Snails
7.
Drug News Perspect ; 19(7): 381-92, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17080201

ABSTRACT

Pain is a multidimensional sensory experience, and multiple mechanisms are involved in the generation of pathophysiological nociceptive pain. Identification of the mechanisms and molecular components responsible for pain generation has not only advanced our understanding of pain and its control, but has also led to the selection of new targets for designing novel analgesic drugs. The high selectivity and specificity of animal toxins have enabled their use as potential therapeutics in the treatment of pain and candidates for the development of new analgesic drugs. This review focuses on the use of animal toxins for pain control and examines the possible analgesic mechanisms of these molecules.


Subject(s)
Analgesics/pharmacology , Pain/drug therapy , Toxins, Biological/pharmacology , Animals , Anura , Conus Snail , Humans , Mollusk Venoms/pharmacology , Pain/physiopathology , Scorpion Venoms/pharmacology , Snake Venoms/pharmacology , Spider Venoms/pharmacology
8.
Neurosci Lett ; 258(1): 57-9, 1998 Dec 11.
Article in English | MEDLINE | ID: mdl-9876051

ABSTRACT

The role of L-,N-, P- and Q-type voltage-dependent calcium channels in K+-induced release of [3H]adenine nucleotides from rat brain cortical synaptosomes was investigated. Cd2+, a non-specific blocker of calcium channels, inhibited by 69% the release of the nucleotides induced by 33 mM K+. Nifedipine, omega-Conotoxin GVIA and omega-Agatoxin IVA had no effect whereas omega-Conotoxin MVIIC inhibited by 62% the K+ induced release of adenine nucleotides in rat brain cortical synaptosomes. It is concluded that Q-type calcium channels are directly involved in the release of adenine nucleotides in rat brain cortical synaptosomes.


Subject(s)
Adenine Nucleotides/metabolism , Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Cerebral Cortex/metabolism , Potassium/pharmacology , Synaptosomes/metabolism , omega-Conotoxins , Animals , Cadmium/pharmacology , Calcium Channels/drug effects , Female , Male , Mollusk Venoms/pharmacology , Nifedipine/pharmacology , Peptides/pharmacology , Rats , Rats, Wistar , Spider Venoms/pharmacology , Tritium , omega-Agatoxin IVA , omega-Conotoxin GVIA
9.
J Physiol ; 497 ( Pt 3): 687-97, 1996 Dec 15.
Article in English | MEDLINE | ID: mdl-9003554

ABSTRACT

1. The involvement of the different types of voltage-dependent calcium channels (VDCCs) in synaptic transmission at the mature and newly formed mammalian neuromuscular junction was studied by evaluating the effects of L-, P/Q- and N-type VDCC antagonists on transmitter release in normal and reinnervating levator auris preparations of adult mice. 2. Nerve-evoked transmitter release was blocked by omega-agatoxin IVA (omega-AgaIVA), a P/Q-type VDCC blocker, both in normal and reinnervating endplates (100 nM omega-AgaIVA caused > 90% inhibition). The N-type VDCC antagonist omega-conotoxin GVIA (omega-CgTX; 1 and 5 microM), as occurs in normal preparations, did not significantly affect this type of release during reinnervation. Nitrendipine (1-10 microM), an L-type VDCC blocker, strongly antagonized release in reinnervating muscles (approximately 40-69% blockade) and lacked any effect in normal preparations. 3. In reinnervating muscles, spontaneous release was not dependent on Ca2+ entry through either P- or L-type VDCCs. Neither 100 nM omega-AgaIVA nor 10 microM nitrendipine affected the miniature endplate potential (MEPP) frequency or amplitude. 4. At the newly formed endplates, K(+)-evoked release was dependent on Ca2+ entry through VDCCs of the P-type family (100 nM omega-AgaIVA reduced approximately 70% of the K(+)-evoked MEPP frequency). L-type VDCCs were found not to participate in this type of release (10 microM nitrendipine lacked any effect). 5. In reinnervating muscles, the L-type VDCC blocker, nitrendipine (10 microM), provoked a significant increase (approximately 25%) in the latency of the evoked endplate potential (EPP). This drug also caused an increase (approximately 0.3 ms) in the latency of the presynaptic currents. The P/Q- and Ny-type VDCC blockers did not affect the latency of the EPP. 6. These results show that at newly formed mouse neuromuscular junctions, as occurs in mature preparations, VDCCs of the P-type family play a prominent role in evoked transmitter release whereas N-type channels are not involved in this process. In addition, signal conduction and transmitter release become highly sensitive to nitrendipine during reinnervation. This suggests that L-type VDCCs may play a role in synaptic transmission at the immature mammalian neuromuscular junction.


Subject(s)
Calcium Channels/physiology , Neuromuscular Junction/physiology , Synaptic Transmission/physiology , Animals , Calcium Channel Blockers/pharmacology , Evoked Potentials , Male , Mice , Mollusk Venoms/pharmacology , Nitrendipine/pharmacology , Peptides/pharmacology , Potassium/pharmacology , Regeneration , Spider Venoms/pharmacology , omega-Agatoxin IVA , omega-Conotoxin GVIA
10.
Braz J Med Biol Res ; 29(12): 1759-63, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9222441

ABSTRACT

The article contains a brief review on the properties and classification of voltage-dependent Ca2+ channels and on the organic blockers of the different channel types. The effects of peptide toxins from the venoms of Conus sp and of the spider Agelenopsis aperta on high voltage-activated Ca2+ channels are discussed. In addition, we present preliminary data on a novel peptide toxin purified from the venom of the spider Phoneutria nigriventer, which is a powerful blocker of L- and N-type Ca2+ channels.


Subject(s)
Calcium Channels/drug effects , Calcium Channels/physiology , Neurotoxins/pharmacology , Animals , Calcium Channel Blockers , Mollusk Venoms/pharmacology , Spider Venoms/pharmacology
11.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;29(12): 1759-63, Dec. 1996. ilus
Article in English | LILACS | ID: lil-188462

ABSTRACT

The article contains a brief review on the properties and classification of voltage-dependent Ca2+ channels and on the organic blockers of the different channel types. The effects of peptide toxins from the venoms of Conus sp and of the spider Agelenopsis aperta on high voltage-activated Ca2+ channels are discussed. In addition, we present preliminary data on a novel peptide toxin purified from the venom of the spider Phoneutria nigriventer, which is a powerful blocker of L-and N-type Ca2+ channels.


Subject(s)
Animals , Calcium Channels/drug effects , Calcium Channels/physiology , Neurotoxins/pharmacology , Calcium Channel Blockers , Mollusk Venoms/pharmacology , Spider Venoms/pharmacology
12.
J Neurochem ; 66(4): 1440-7, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8627296

ABSTRACT

Ouabain, an Na+K+ATPase inhibitor, increases the release of acetylcholine (ACh) from various preparations in a Ca2+ -independent way. However, in other preparations the release of ACh evoked by ouabain is dependent on the presence of extracellular calcium. In the present study, we have labeled the ACh of myenteric plexus longitudinal muscles of guinea pig ileum and compared the effect of calcium channel blockers on ouabain-evoked release of [3H]ACh. Release of [3H]ACh evoked by ouabain is dose dependent and decreased markedly in the absence of calcium or in the presence of cadmium, a nonspecific calcium channel blocker. N-type calcium channel blockage by the omega-conotoxins GVIA (selective N-type calcium channel blocker) and MVIC (a nonselective calcium channel blocker) inhibited by 45 and 55%, respectively, the release of [3H]ACh. L-type calcium channel suppression by low concentrations of verapamil, nifedipine, and diltiazem had no effect on the release of [3H]ACh. The release of transmitter was also not affected significantly by nickel, a T-type calcium channel blocker. In addition, omega-agatoxin-IVA, at concentrations that block P- and Q-type calcium channels, did not affect significantly the release of [3H]ACh. Thus, extracellular Ca2+ is essential for the release of ACh induced by ouabain from guinea pig ileum myenteric plexus. In this preparation, the N-type calcium channel plays a dominant role in transmitter release evoked by inhibition of Na+K+-ATPase, but other routes of calcium entry in addition to these channels can also support the release of neurotransmitter induced by ouabain.


Subject(s)
Acetylcholine/metabolism , Calcium Channels/metabolism , Enzyme Inhibitors/pharmacology , Myenteric Plexus/enzymology , Ouabain/pharmacology , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , omega-Conotoxins , Animals , Cadmium/pharmacology , Calcium/metabolism , Calcium Channel Blockers/pharmacology , Dose-Response Relationship, Drug , Female , Guinea Pigs , Ileum/enzymology , Ileum/innervation , Ion Channel Gating/physiology , Male , Mollusk Venoms/pharmacology , Muscles/enzymology , Muscles/ultrastructure , Myenteric Plexus/ultrastructure , Peptides/pharmacology , Spider Venoms/pharmacology , Tritium/metabolism , omega-Agatoxin IVA , omega-Conotoxin GVIA
13.
J Neurochem ; 64(6): 2544-51, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7760034

ABSTRACT

The voltage-dependent calcium channels present in mammalian and chicken brain synaptosomes were characterized pharmacologically using specific blockers of L-type channels (1,4-dihydropyridines), N-type channels (omega-conotoxin GVIA), and P-type channels [funnel web toxin (FTX) and omega-agatoxin IVA]. K(+)-induced Ca2+ uptake by chicken synaptosomes was blocked by omega-conotoxin GVIA (IC50 = 250 nM). This toxin at 5 microM did not block Ca2+ entry into rat frontal cortex synaptosomes. FTX and omega-agatoxin IVA blocked Ca2+ uptake by rat synaptosomes (IC50 = 0.17 microliter/ml and 40 nM, respectively). Likewise, in chicken synaptosomes, FTX and omega-agatoxin IVA affected Ca2+ uptake, FTX (3 microliters/ml) exerted a maximal inhibition of 40% with an IC50 similar to the one obtained in rat preparations, whereas with omega-agatoxin IVA saturation was not reached even at 5 microM. In chicken preparations, the combined effect of saturating concentrations of FTX (1 microliter/ml) and different concentrations of omega-conotoxin GVIA showed no additive effects. However, the effect of saturating concentrations of FTX and omega-conotoxin GVIA was never greater than the one observed with omega-conotoxin GVIA. We also found that 60% of the Ca2+ uptake by rat and chicken synaptosomes was inhibited by omega-conotoxin MVIID (1 microM), a toxin that has a high index of discrimination against N-type channels. Conversely, nitrendipine (10 microM) had no significant effect on Ca2+ uptake in either the rat or the chicken. In conclusion, Ca2+ uptake by rat synaptosomes is potently inhibited by different P-type Ca2+ channel blockers, thus indicating that P-type channels are predominant in this preparation.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Brain/metabolism , Calcium Channels/physiology , Synaptosomes/metabolism , Animals , Cadmium/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Chickens , Electrophysiology , Male , Mollusk Venoms/pharmacology , Polyamines/pharmacology , Potassium/pharmacology , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL